Professor Stefan Klaus Bohlander

Professor

In: Molecular Medicine and Pathology » Medical Science » Faculty of Medical and Health Sciences

Selected publications and creative works (Research Outputs)

Braess, J., Amler, S., Kreuzer, K.-A., Spiekermann, K., Lindemann, H. W., Lengfelder, E., ... Biersack, H. (2018). Sequential high-dose cytarabine and mitoxantrone (S-HAM) versus standard double induction in acute myeloid leukemia-a phase 3 study. Leukemia, 32 (12), 2558-2571. 10.1038/s41375-018-0268-9
Hornung, R., Jurinovic, V., Batcha, A. M. N., Bamopoulos, S. A., Rothenberg-Thurley, M., Amler, S., ... BohlanderSK (2018). Mediation analysis reveals common mechanisms of RUNX1 point mutations and RUNX1/RUNX1T1 fusions influencing survival of patients with acute myeloid leukemia. Scientific Reports, 8 (1).10.1038/s41598-018-29593-2
Wei, A. H., Chua, C. C., Tiong, I. S., Fong, C. Y., Ting, S. B., Macraild, S., ... Yuen, F. (2018). Molecular Patterns of Response and Outcome in the Chemotherapy and Venetoclax in Elderly AML Trial (CAVEAT study). Paper presented at 60th Annual Meeting of the American-Society-of-Hematology (ASH), San Diego, CA. 1 December - 4 December 2018. BLOOD. (pp. 3). 10.1182/blood-2018-99-114243
Opatz, S., Vosberg, S., Ksienzyk, B., Tschuri, S., Graf, A., Krebs, S., ... Baldus, C. D. (2018). Clonal Evolution of Relapsed CBFB/MYH11 Rearranged Acute Myeloid Leukemia (AML). Paper presented at 60th Annual Meeting of the American-Society-of-Hematology (ASH), San Diego, CA. 1 December - 4 December 2018. BLOOD. (pp. 3). 10.1182/blood-2018-99-115881
Barbosa, K. O., Ghosh, A., Deshpande, A., Dutta, S., Armstrong, S. A., Bohlander, S. K., & Deshpande, A. J. (2018). Genetic or Pharmacological Inhibition of the Polycomb Group Protein BMI1 Impairs Leukemic Transformation Mediated By the CALM-AF10Fusion Oncoprotein. Paper presented at 60th Annual Meeting of the American-Society-of-Hematology (ASH), San Diego, CA. 1 December - 4 December 2018. BLOOD. (pp. 2). 10.1182/blood-2018-99-115552
Rothenberg-Thurley, M., Herold, T., Goerlich, D., Sauerland, C., Janke, H., Prassek, V. V., ... Ksienzyk, B. (2018). NPM1 Variant Allele Frequency and Outcomes in AML. Paper presented at 60th Annual Meeting of the American-Society-of-Hematology (ASH), San Diego, CA. 1 December - 4 December 2018. BLOOD. (pp. 6). 10.1182/blood-2018-99-112549
Prassek, V. V., Rothenberg-Thurley, M., Sauerland, M. C., Herold, T., Janke, H., Ksienzyk, B., ... Faldum, A. (2018). Genetics of acute myeloid leukemia in the elderly: mutation spectrum and clinical impact in intensively treated patients aged 75 years or older. Haematologica, 103 (11), 1853-1861. 10.3324/haematol.2018.191536
Konstandin, N. P., Pastore, F., Herold, T., Dufour, A., Rothenberg-Thurley, M., Hinrichsen, T., ... Hoster, E. (2018). Genetic heterogeneity of cytogenetically normal AML with mutations of CEBPA. BLOOD ADVANCES, 2 (20), 2724-2731. 10.1182/bloodadvances.2018016840